California Institute for Biomedical Research Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2017
NCT03133676
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Calibr, a division of Scripps Research | California Institute for Biomedical Research